ZEB1 and leukemia: MEF2C (often deregulated and associated with recurrence in leukemia [34]) and ZEB1 (shown to modulate hematopoietic stem cell fates [35, 36]) are also inactive in the blood (TF activity -0.882 and -1.532, respectively).